Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed
Authors
Keywords
Pharmacogenetics, Antipsychotics, Weight gain, Clozapine, Olanzapine, Epigenetics, Serum levels, Biomarkers
Journal
Current Psychiatry Reports
Volume 16, Issue 10, Pages -
Publisher
Springer Nature
Online
2014-08-19
DOI
10.1007/s11920-014-0473-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Side effects of atypical antipsychotics: a brief overview
- (2015) ALP ÜÇOK et al. World Psychiatry
- Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances
- (2014) A.C.C. Kao et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A “Glucose Eater” Drug as a Therapeutic Agent in Psychiatry
- (2014) Robert H. Howland JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
- Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study
- (2014) Emily C. Shing et al. NEUROPSYCHOBIOLOGY
- Association ofFTO,LEPRandMTHFRgene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics
- (2014) Siti Norsyuhada Roffeei et al. PHARMACOGENOMICS
- Genetic variation in theGCGand in theGLP1Rgenes and antipsychotic-induced weight gain
- (2014) Eva J Brandl et al. PHARMACOGENOMICS
- Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
- (2014) Pelle L Ishøy et al. BMJ Open
- The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum
- (2014) Melkaye G Melka et al. Clinical Epigenetics
- Weight Loss Intervention for Individuals with Diabetes and Serious Mental Illness: A Pragmatic Experiment in Community Settings
- (2013) Rohan Ganguli et al. Canadian Journal of Diabetes
- The pharmacogenetics of antipsychotic-induced adverse events
- (2013) Daniel J. Müller et al. CURRENT OPINION IN PSYCHIATRY
- Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone
- (2013) Siti Norsyuhada Roffeei et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Exploratory study on association of genetic variation inTBC1D1with antipsychotic-induced weight gain
- (2013) Eva J. Brandl et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?
- (2013) Fabian Czerwensky et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia
- (2013) Umarat Srisawat et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Polymorphisms of the Histamine Receptor (H1HR) Gene Are Not Associated With Olanzapine-Induced Weight Gain
- (2013) Beata R. Godlewska et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Detection of Metabolic Syndrome in Schizophrenia and Implications for Antipsychotic Therapy
- (2013) Kyle J. Burghardt et al. Molecular Diagnosis & Therapy
- Genetics of antipsychotic-induced weight gain: update and current perspectives
- (2013) Amy CC Kao et al. PHARMACOGENOMICS
- Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population
- (2013) Xiaofeng Hu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
- (2013) E L Nurmi et al. Translational Psychiatry
- Regulation of Glucose Transporter Translocation in Health and Diabetes
- (2012) Jonathan S. Bogan Annual Review of Biochemistry
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways
- (2012) Maja Pijet et al. CYTOKINE
- Finite mixture regression model analysis on antipsychotics induced weight gain: Investigation of the role of the serotonergic genes
- (2012) Behdin Nowrouzi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
- (2012) Gavin P. Reynolds et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients
- (2012) Arun K. Tiwari et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of the Common MC4R rs17782313 Polymorphism With Antipsychotic-Related Weight Gain
- (2012) Fabian Czerwensky et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia
- (2012) S A Lott et al. PHARMACOGENOMICS JOURNAL
- Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population
- (2012) B Almoguera et al. PHARMACOGENOMICS JOURNAL
- Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
- (2012) N I Chowdhury et al. PHARMACOGENOMICS JOURNAL
- Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
- (2012) E.J. Brandl et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences
- (2012) Kyle J Burghardt et al. Epigenomics
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
- (2011) T A P Lett et al. MOLECULAR PSYCHIATRY
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
- (2010) M A Febbraio et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight
- (2010) Jessica Bah et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
- (2010) Arun K Tiwari et al. NEUROPSYCHOPHARMACOLOGY
- Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis
- (2010) Michelle N Sicard et al. PHARMACOGENOMICS
- What Is Epigenetics?
- (2010) Guy Riddihough et al. SCIENCE
- Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study
- (2009) S. Gebhardt et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia
- (2009) María del Rosario García-Miss et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
- (2009) B. P. F. Rutten et al. SCHIZOPHRENIA BULLETIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search